| Issue | Title | |
| Vol 4, No 2 (2012): Mol Cell Pharmacol | A Main Role for Metabotropic Glutamate Receptor 1 in the Neuroprotective Effect of Estrogen | Abstract PDF |
| Simona Federica Spampinato, Sara Merlo, Ferdinando Nicoletti, Maria Angela Sortino | ||
| Vol 1, No 5 (2009): Mol Cell Pharmacol | A Potential Preclinical Migraine Model: CGRP-Sensitized Mice | Abstract PDF |
| Andrew F. Russo, Adisa Kuburas, Eric A. Kaiser, Ann C. Raddant, Ana Recober | ||
| Vol 1, No 4 (2009): Mol Cell Pharmacol | Abuse Potential of Soma®: the GABAA Receptor as a Target | Abstract PDF |
| Lorie A. Gonzalez, Michael B. Gatch, Michael J. Forster, Glenn H. Dillon | ||
| Vol 9, No 3 (2017): Mol Cell Pharmacol | Alectinib (Alecensa) as First-line Option for ALK-positive Lung Cancer | Abstract PDF |
| M. Saeed Sheikh | ||
| Vol 1, No 1 (2009): Mol Cell Pharmacol | Anti-Inflammatory Agents for Cancer Therapy | Abstract PDF |
| Elizabeth R. Rayburn, Scharri J. Ezell, Ruiwen Zhang | ||
| Vol 4, No 3 (2012): Mol Cell Pharmacol: Our Endless War with Microbes | Anti-parasite Drug Targets in The Post-genome Era: What Have We Learned and What's Next? | Abstract PDF |
| Sailen Barik | ||
| Vol 4, No 2 (2012): Mol Cell Pharmacol | Anticancer Activity and Molecular Mechanisms of Action of Makaluvamines and Analogues | Abstract PDF |
| Subhasree Nag, Dwayaja H. Nadkarni, Jiang-Jiang Qin, Sukesh Voruganti, Thao Nguyen, Su Xu, Wei Wang, Hui Wang, Sadanandan E. Velu, Ruiwen Zhang | ||
| Vol 4, No 3 (2012): Mol Cell Pharmacol: Our Endless War with Microbes | Apicomplexan Cyclophilins in Host-parasite Interaction and Their Potential as Anti-parasitic Drug Targets | Abstract PDF |
| Hany M. Ibrahim, Yoshifumi Nishikawa | ||
| Vol 5, No 2 (2013): Mol Cell Pharmacol | Artemisinin and Biomolecules: the Continuing Search for Mechanism of Action | Abstract PDF |
| Nkereuwem Edikpo, Samuel Ghasi, Adikwu Elias, Nelson Oguanobi | ||
| Vol 2, No 5 (2010): Mol Cell Pharmacol | Attenuation of Doxorubicin-induced Cardiotoxicity by Tadalafil: A Long Acting Phosphodiesterase-5 Inhibitor | Abstract PDF |
| Saisudha Koka, Rakesh C Kukreja | ||
| Vol 3, No 2 (2011): Mol Cell Pharmacol | Bladder Selectivity of Imidafenacin, a Novel Antimuscarinic Agent Developed to Treat Overactive Bladder | Abstract PDF |
| Shizuo Yamada, Akira Yoshida, Masaki Ogoda, Yusuke Fuchihata, Shiori Kuraoka, Hideo Tsukada, Tsuyoshi Anraku | ||
| Vol 7, No 1 (2015): Mol Cell Pharmacol | Carisoprodol: Update on Abuse Potential and Mechanism of Action | Abstract PDF |
| Manoj Kumar, Glenn H. Dillon | ||
| Vol 2, No 2 (2010): Mol Cell Pharmacol | Characterization of Human Homeodomain-interacting Protein Kinase 4 (HIPK4) as a Unique Member of the HIPK Family | Abstract PDF |
| Qin He, Jingxue Shi, Hong Sun, Jie An, Ying Huang, M. Saeed Sheikh | ||
| Vol 1, No 2 (2009): Mol Cell Pharmacol | Chemotherapeutics of Neglected Waterborne Parasites: Current Status and Future Perspectives | Abstract PDF |
| Ratna Chakrabarti, Debopam Chakrabarti | ||
| Vol 5, No 1 (2013): Mol Cell Pharmacol: New Insights in the Cellular and Molecular Response to Radiation Therapy | Chromatin Modulation by Histone Deacetylase Inhibitors: Impact on Cellular Sensitivity to Ionizing Radiation | Abstract PDF |
| France Carrier | ||
| Vol 3, No 3 (2011): Mol Cell Pharmacol: MicroRNAs in Health and Disease | Circulating MicroRNA as Biomarkers: An Update in Prostate Cancer | Abstract PDF |
| Anvesha Srivastava, Simeng Suy, Sean P Collins, Deepak Kumar | ||
| Vol 1, No 5 (2009): Mol Cell Pharmacol | Compound-Induced Block of Ion Channel Pore Function: Inward-Rectifier Potassium Channels as a Model | Abstract PDF |
| Kazuharu Furutani, Hiroshi Hibino, Atsushi Inanobe, Yoshihisa Kurachi | ||
| Vol 1, No 4 (2009): Mol Cell Pharmacol | Corrigendum to: Differentiation of cochlear neural progenitors with SV40 in vitro. Mol Cell Pharmacol 2009;1:11-22 | Details PDF |
| Jizhen Lin | ||
| Vol 7, No 3 (2015): Mol Cell Pharmacol | Curcumin-encapsulating Nanogels as an Effective Anticancer Formulation for Intracellular Uptake | Abstract PDF |
| Anna Reeves, Serguei V. Vinogradov, Phil Morrissey, Mitchell Chernin Chernin, Mansoor M. Ahmed | ||
| Vol 2, No 3 (2010): Mol Cell Pharmacol | Cyclosporin A Enhances Cell Survival in Neural Precursor Populations in the Adult Central Nervous System | Abstract PDF |
| Jessica Hunt, Cindi Morshead | ||
| Vol 2, No 2 (2010): Mol Cell Pharmacol | Decision Making by p53: Life versus Death | Abstract PDF |
| Lingyan Jiang, M. Saeed Sheikh, Ying Huang | ||
| Vol 1, No 3 (2009): Mol Cell Pharmacol | Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway | Abstract PDF |
| Ling-Hui Zeng, Nicholas R. Rensing, Michael Wong | ||
| Vol 4, No 1 (2012): Mol Cell Pharmacol | Differential Expression of Key Signaling Proteins in MCF10 Cell Lines, a Human Breast Cancer Progression Model | Abstract PDF |
| Jae Young So, Hong Jin Lee, Pavel Kramata, Audrey Minden, Nanjoo Suh | ||
| Vol 1, No 1 (2009): Mol Cell Pharmacol | Differentiation of cochlear neural progenitors with SV40 in vitro | Abstract PDF |
| Ling Feng, Yuki Hamajima, Masahiro Komori, John Anderson, Dong Wang, Terry C. Burns, Catherine M. Verfaillie, Walter C. Low, Jizhen Lin | ||
| Vol 2, No 3 (2010): Mol Cell Pharmacol | DP2 Receptor Antagonists: Novel Therapeutic Target for COPD | Abstract PDF |
| Karin J. Stebbins, Jilly F. Evans, Daniel S. Lorrain | ||
| Vol 2, No 1 (2010): Mol Cell Pharmacol | DrugBank: A General Resource for Pharmaceutical and Pharmacological Research | Abstract PDF |
| David S. Wishart | ||
| Vol 3, No 2 (2011): Mol Cell Pharmacol | Effects of Histone Deacetylase Inhibitors on Modulating H3K4 Methylation Marks – A Novel Cross-Talk Mechanism between Histone-Modifying Enzymes | Abstract PDF |
| Po-Hsien Huang, Christoph Plass, Ching-Shih Chen | ||
| Vol 1, No 5 (2009): Mol Cell Pharmacol | Endothelin-1, an Endogenous Irreversible Agonist in Search of an Allosteric Inhibitor | Abstract PDF |
| Jo G.R. De Mey, Matthijs G. Compeer, Merlijn J. Meens | ||
| Vol 1, No 4 (2009): Mol Cell Pharmacol | Enhancement of Gamma Radiation-induced Cytotoxicity of Breast Cancer Cells by Curcumin | Abstract PDF |
| Swati Girdhani, Mansoor M. Ahmed, Kaushala P. Mishra | ||
| Vol 2, No 5 (2010): Mol Cell Pharmacol | Epigenetic Reactivation of Estrogen Receptor: Promising Tools for Restoring Response to Endocrine Therapy | Abstract PDF |
| Neeraj K Saxena, Dipali Sharma | ||
| Vol 1, No 1 (2009): Mol Cell Pharmacol | Epigenetic Targeting of Transforming Growth Factor β Receptor II and Implications for Cancer Therapy | Abstract PDF |
| Sanjib Chowdhury, Sudhakar Ammanamanchi, Gillian M. Howell | ||
| Vol 1, No 5 (2009): Mol Cell Pharmacol | Estrogen’s Place in the Family of Synaptic Modulators | Abstract PDF |
| Enikö A. Kramár, Lulu Y. Chen, Christopher S. Rex, Christine M. Gall, Gary Lynch | ||
| Vol 3, No 1 (2011): Mol Cell Pharmacol | Evaluation of Anticancer Properties of Medicinal Plants from the Indian Sub-Continent | Abstract PDF |
| Akbar Nawab, Mohammad Yunus, Abbas A Mahdi, Sanjay Gupta | ||
| Vol 1, No 3 (2009): Mol Cell Pharmacol | Extraction, Characterization, Stability and Biological Activity of Flavonoids Isolated from Chamomile Flowers | Abstract PDF |
| Janmejai K. Srivastava, Sanjay Gupta | ||
| Vol 9, No 3 (2017): Mol Cell Pharmacol | FDA Approval Brings First Gene Therapy to the United States | Abstract PDF |
| FDA News Release | ||
| 1 - 35 of 224 Items | 1 2 3 > >> | |
LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041
Copyright © 2008 LumiText Publishing. All rights reserved.